Price chart
Loading 1Y daily…
Financial overlay · last 12 quarters
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100.4B | $2.9B | $4.7B | $3.4B | 2.9% | 4.7% |
| 2025-12-31 | $105.7B | $2.9B | $2.1B | $2.6B | 2.8% | 2.0% |
| 2025-09-30 | $102.9B | $-4.0B | $2.5B | $0.1B | -3.9% | 2.4% |
| 2025-06-30 | $98.9B | $1.0B | $2.4B | $1.3B | 1.0% | 2.4% |
| 2025-03-31 | $94.6B | $1.8B | $3.4B | $3.8B | 1.9% | 3.6% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
| 2024-09-30 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Earnings replay · last 20 reports
| Date | EPS actual | EPS est | Surprise |
|---|---|---|---|
| 2026-05-06 | 2.57 | 2.21 | +16.5% |
| 2026-02-10 | 1.09 | 1.00 | +9.4% |
| 2025-10-29 | -3.13 | 0.95 | -430.1% |
| 2025-07-31 | 1.81 | 1.46 | +23.9% |
| 2025-05-01 | 2.25 | 1.67 | +34.5% |
| 2025-02-12 | 1.19 | 0.92 | +29.6% |
| 2024-11-06 | 1.09 | 1.46 | -25.2% |
| 2024-08-07 | 1.83 | 1.73 | +6.0% |
| 2024-05-01 | 1.31 | 1.70 | -22.8% |
| 2024-02-07 | 2.12 | 1.99 | +6.6% |
| 2023-11-01 | 2.21 | 2.13 | +3.7% |
| 2023-08-02 | 2.21 | 2.12 | +4.2% |
| 2023-05-03 | 2.20 | 2.09 | +5.2% |
| 2023-02-08 | 1.99 | 1.93 | +3.1% |
| 2022-11-02 | 2.15 | 1.99 | +7.9% |
| 2022-08-03 | 2.40 | 2.18 | +10.1% |
| 2022-05-04 | 2.22 | 2.15 | +3.5% |
| 2022-02-09 | 1.98 | 1.88 | +5.4% |
| 2021-11-03 | 1.97 | 1.79 | +10.3% |
| 2021-08-04 | 2.42 | 2.07 | +17.1% |
Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).
Peer comparison · Healthcare
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| CVS ★ | $114B | 39.3 | 10.7 | 0.3 | 11.7 | 1.5 | 13.4% | 6.1% | 63.1% | 4.56% |
| LLY | $949B | 37.7 | 23.9 | 13.1 | 27.3 | 30.5 | 82.8% | 55.5% | 169.9% | 0.96% |
| UNH | $343B | 28.5 | 18.1 | 0.8 | 18.5 | 3.5 | 18.8% | 2.0% | 0.7% | 5.15% |
| JNJ | $537B | 25.8 | 17.5 | 5.6 | 16.6 | 6.6 | 68.0% | 9.9% | -52.9% | 2.33% |
| MRK | $286B | 32.6 | 12.1 | 4.3 | 11.2 | 6.2 | 76.7% | 4.9% | — | 4.92% |
| ABBV | $381B | 105.6 | 13.3 | 6.1 | 14.8 | -57.2 | 72.0% | 12.4% | -46.2% | 5.47% |
| PFE | $146B | 19.5 | 9.0 | 2.3 | 7.8 | 1.6 | 74.8% | 5.4% | -10.1% | 8.50% |
| TMO | $179B | 26.5 | 17.7 | 4.0 | 19.4 | 3.4 | 40.9% | 6.2% | 11.3% | 3.08% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Top institutional holders
Top-10 concentration: 42.19%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 125,919,853 | 9.87% |
| Vanguard Capital Management LLC | 82,650,076 | 6.48% |
| Capital World Investors | 77,248,642 | 6.05% |
| State Street Corporation | 59,322,181 | 4.65% |
| Dodge & Cox Inc. | 51,780,116 | 4.06% |
| FMR, LLC | 31,196,890 | 2.45% |
| JPMORGAN CHASE & CO | 29,527,125 | 2.31% |
| Geode Capital Management, LLC | 29,459,042 | 2.31% |
| Vanguard Portfolio Management LLC | 25,997,348 | 2.04% |
| Invesco Ltd. | 25,138,946 | 1.97% |
Insider activity · 90d
No insider trades for CVS in last 90d.
Analyst estimates
yfinanceConsensus: strong_buy (mean 1.5). Distribution requires FINNHUB_API_KEY.
SEC filings
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-06-01 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-01 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-22 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-18 | 8-K | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-11 | PRIMARY DOCUMENT | view · |
| 13F-HR | 2026-05-07 | Institutional holdings (13F) | view · |
| 10-Q | 2026-05-06 | 10-Q | view · |
| 8-K | 2026-05-06 | 8-K | view · |
| DEF 14A | 2026-04-03 | DEFINITIVE PROXY STATEMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-20 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-03-19 | 8-K | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 13F-HR | 2026-02-13 | Institutional holdings (13F) | view · |
| 10-K | 2026-02-10 | 10-K | view · |
| 8-K | 2026-02-10 | 8-K | view · |
| 4 | 2026-01-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-01-05 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-12-09 | 8-K | view · |
| 4 | 2025-12-02 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-02 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-02 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-02 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-11-20 | 8-K | view · |
| 13F-HR | 2025-10-31 | Institutional holdings (13F) | view · |
| 10-Q | 2025-10-29 | 10-Q | view · |
| 8-K | 2025-10-29 | 8-K | view · |
About
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health …